Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: An evaluation of 2 placebo-controlled maintenance trials

Journal of Clinical Psychiatry

Volumn 67, Issue 11, 2006, Pages 1721-1728

  Frye, Mark A ^a,i   Yatham, Lakshmi N ^b   Calabrese, Joseph R ^c   Bowden, Charles L ^d   Ketter, Terence A ^e   Suppes, Trisha ^f   Adams, Bryan E ^g,h   Thompson, Thomas R ^g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Mays Cancer Center at UT Health San Antonio   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^g GLAXOSMITHKLINE   (United States)

^h Clinforce Inc   (United States)

ⁱ MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAMOTRIGINE; LITHIUM; PSYCHOTROPIC AGENT;

ARTICLE; BIPOLAR I DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG WITHDRAWAL; FUNCTIONAL DISEASE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MANIA; MOOD CHANGE; MOOD DISORDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; REMISSION; SUBSYNDROMAL MOOD SYMPTOM; SYMPTOMATOLOGY;

EID: 33845603568     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v67n1108     Document Type: Article

References (23)

1. Judd LL, Akiskal HS, Schettler PJ, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002;59:530-53 7
2. Judd LL, Akiskal HS, Schettler PJ, et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 2003;60:261-269
3. Joffe RT, MacQueen GM, Marriott M, et al. A prospective, longitudinal study of percentage of time spent ill in patients with bipolar I and bipolar II disorders. Bipolar Disord 2004;6:62-66
4. Yatham LN, Lecrubier Y, Fieve RR, et al. Quality of life in patients with bipolar I depression: data from 920 patients. Bipolar Disord 2004; 6:379-385
5. Altshuler LL, Gitlin MJ, Mintz J, et al. Subsyndromal depression is associated with functional impairment in patients with bipolar disorder. J Clin Psychiatry 2002;63:807-811
6. MacQueen GM, Marriott M, Begin H, et al. Subsyndromal symptoms assessed in longitudinal, prospective follow-up of a cohort of patients with bipolar disorder. Bipolar Disord 2003;5:349-355
7. Judd LL, Akiskal HS. The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. J Affect Disord 2003;73:123-131
8. Keller MB, Lavori PW, Kane JM, et al. Subsyndromal symptoms in bipolar disorder: a comparison of standard and low serum levels of lithium. Arch Gen Psychiatry 1992;49:371-376
9. Marangell LB. The importance of Subsyndromal symptoms in bipolar disorder. J Clin Psychiatry 2004;65(suppl 10):24-27
10. Bowden CL, Calabrese JR, Sachs G, et al. A placebo-controlled, 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003;60:392-400
11. Calabrese JR, Bowden CL, Sachs G, et al. A placebo-controlled, 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 2003;64:1013-1024
12. Goodwin GM, Bowden CL, Calabrese JR, et al. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 2004;65:432-441
13. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Press; 1994
14. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976:218-222
15. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
16. Endicott J, Spitzer RL. A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 1978;35:837-844
17. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20:37-46
18. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174
19. McQuade R, Sanchez R, Marcus R, et al. Aripiprazole for relapse prevention in bipolar disorder: a 26-week placebo-controlled study. Presented at the 24th Congress of the Collegium Internationale Neuropsychopharmacologicum; June 20-24, 2004; Paris, France
20. Tohen M, Calabrese JR, Sachs GS, et al. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine. Am J Psychiatry 2006;163:247-256
21. Calabrese JR, Vieta E, El-Mallakh R, et al. Mood state at study entry as predictor of the polarity of relapse in bipolar disorder. Biol Psychiatry 2004;56:957-963
22. Goodnick PJ, Fieve RR, Schlegel A, et al. Predictors of interepisode symptoms and relapse in affective disorder patients treated with lithium carbonate. Am J Psychiatry 1987; 144:367-369
23. Cassidy F, Aheam E, Carroll B. A prospective study of inter-episode consistency of manic and mixed subtypes of bipolar disorder. J Affect Disord 2001;67:181-185